Efficacy and safety of Shexiang Baoxin Pill for stable coronary artery disease: A systematic review and meta-analysis of 42 randomized controlled trials

Objective: Patients with stable coronary artery disease (SCAD) still have a higher risk of adverse cardiovascular events. Shexiang Baoxin Pill (SBP) is widely used as a complementary and alternative treatment for SCAD. This study aimed to further verify the therapeutic effect and safety of SBP on SC...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jingjing, Ma, Teng, Zhou, Cheng, Hao, Pengle, Li, Bin, Wang, Xinlu, Yu, Rui, Zhu, Mingjun, Wang, Yongxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701736/
https://www.ncbi.nlm.nih.gov/pubmed/36452225
http://dx.doi.org/10.3389/fphar.2022.1002713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701736/
https://www.ncbi.nlm.nih.gov/pubmed/36452225
http://dx.doi.org/10.3389/fphar.2022.1002713

Ejemplares similares